Compare Johnson & Johnson (JNJ) vs Stanley Black & Decker, Inc. (SWK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Stanley Black & Decker, Inc. — how do they compare? Johnson & Johnson trades at $248.49 (market cap $598.96B), while Stanley Black & Decker, Inc. trades at $87.62 (market cap $13.60B). The key difference: Johnson & Johnson is far larger — about 44× Stanley Black & Decker, Inc.'s market cap, and Stanley Black & Decker, Inc. pays the higher dividend (3.79%). Which is the better fit depends on your goals.
| JNJ | SWK | |
|---|---|---|
Market Cap | $598.96B | $13.60B |
Volume | 6,156,228 | — |
Sector | Health | — |
52-Week High | $267.24 | $94.12 |
52-Week Low | $164.36 | $62.12 |
Enterprise Value | $631.90B | $19.77B |
Dividend Yield | 2.15% | 3.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $249.58, down 1.37% today, amid a generally bullish technical outlook with strong moving average signals. The company reported robust Q2 2026 earnings, beating EPS estimates and raising full-year guidance, with revenue growth to $94.19B in 2025 and a net income margin of 21.48%. Recent news highlights strong institutional interest and positive analyst sentiment, though the stock faces pressure from MedTech segment misses despite overall strength.
The outlook for JNJ remains positive, supported by solid fundamentals, a consistent dividend history, and upward revised earnings guidance. Key risks include competitive pressures in pharmaceuticals, regulatory hurdles, and execution challenges in the MedTech division. With a consensus price target of $279.33, representing ~12% upside, the stock offers a compelling opportunity for long-term investors, balanced by sector-specific volatility and macroeconomic factors.
Stanley Black & Decker (SWK) trades at $87.52, down 2.94% on the day, with a bullish technical signal from moving averages and a neutral RSI. The company has beaten earnings estimates for the last three quarters, with Q2 2026 results expected soon. Revenue has stabilized around $15.1B in 2025, while net income improved to $402M. The stock carries a P/E of 36.95 and a dividend yield supported by recent payouts.
SWK shows operational resilience with consistent cash flow and debt reduction, but faces headwinds in Tools & Outdoor demand. Analyst sentiment is mixed with a consensus hold rating; the stock offers value and momentum potential amid ongoing cost-saving initiatives and aerospace growth, though high debt and consumer weakness pose risks to near-term performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Stanley Black & Decker, Inc.
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.
Read more on SWK →
